Market open· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Synthomer has seen its fair value estimate move from £1.47 to £1.28, while published price targets in recent months have sat around 92 GBp and 100 GBp. Analysts have kept ratings at neutral levels around these targets, which points to ongoing debate about how to balance valuation, execution risk and growth assumptions. As you read on, you will see how this evolving price target story can help you track the shifting analyst narrative around Synthomer. Analyst Price Targets don't always capture...
Synthomer PLC (SYHMY) delivers strong first-half results with all divisions growing, upgraded full-year guidance, and a clear path to faster deleveraging.
The latest update on Synthomer centres on a higher fair value estimate, moving from £1.27 to £1.47 in the refreshed model. Street commentary has turned more constructive, with raised price targets in GBp terms broadly aligned with this shift, even as many ratings remain in the neutral camp. As you read on, you will see how this evolving analyst narrative might shape your view on Synthomer and what to watch as the story continues to develop. Stay updated as the Fair Value for Synthomer shifts...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.